NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.440
+0.080 (3.39%)
Nov 11, 2026, 11:41 AM EST - Market open
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $105.56 million as of November 11, 2026. It is the 24,825th most valuable company in the world and the 4,045th biggest in the United States. Its market cap has increased by 110.70% in one year.
Market Cap
105.56M
Enterprise Value
79.71M
1-Year Change
110.70%
Global Rank
Country Rank
#4,045 United States
Category
ChartMarket Cap Chart
Since November 20, 2017, NRx Pharmaceuticals's market cap has increased from $65.80M to $105.56M, an increase of 60.43%. That is a compound annual growth rate of 5.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 105.56M | 38.71% |
| Dec 31, 2025 | 76.10M | 186.09% |
| Dec 31, 2024 | 26.60M | -31.09% |
| Dec 29, 2023 | 38.60M | -48.60% |
| Dec 30, 2022 | 75.10M | -73.28% |
| Dec 31, 2021 | 281.10M | 328.51% |
| Dec 31, 2020 | 65.60M | 2.02% |
| Dec 31, 2019 | 64.30M | -30.26% |
| Dec 31, 2018 | 92.20M | 44.97% |
| Dec 29, 2017 | 63.60M | -3.34% |
| Nov 20, 2017 | 65.80M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Milestone Pharmaceuticals | 107.49M |
| Anavex Life Sciences | 106.60M |
| Outlook Therapeutics | 106.24M |
| Immunic | 105.74M |
| NovaBridge Biosciences | 105.50M |
| TuHURA Biosciences | 103.87M |
| Black Diamond Therapeutics | 99.68M |
| Unicycive Therapeutics | 98.89M |